共 47 条
[1]
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2020, 323 (19)
:1945-1960
[5]
Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
[J].
JOURNAL OF IMMUNOLOGY RESEARCH,
2019, 2019
[9]
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
[J].
FRONTIERS IN IMMUNOLOGY,
2018, 9